2413
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

M3, Inc. operates a global network of medical professional platforms, including m3.com in Japan, MDLinx in the United States, and Doctors.net.uk in the United Kingdom. The company provides marketing support services for pharmaceutical companies, leveraging its platform to facilitate information distribution and conduct surveys among healthcare professionals. Its business segments include Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, Patient Solutions, and Overseas operations. Key services encompass the development and sale of electronic medical records, clinical research organization (CRO) and site management organization (SMO) support, and talent acquisition services for doctors and pharmacists. The group also manages medical facilities, hospice care, and residential care services, while offering patient support products such as care sets for inpatients and care facility residents. In overseas markets, the company provides digital solutions, physician profile database licensing, and clinical trial support services.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Health Information Services Homepage corporate.m3.com
Sector Healthcare IR page corporate.m3.com
Tags
medical platforms, pharmaceutical marketing, electronic medical records, clinical research, healthcare staffing, hospice care, patient support, digital health, m3.com, MDLinx, Doctors.net.uk, m3.com CAREER
Press page corporate.m3.com/news

Metrics

Valuation  
Market cap ¥ 1.202T
Market cap (USD) $ 7.515B
P/E 25.64
PEG 524.13
P/BV 2.70
P/S 3.32
P/OCF 18.58
P/FCF 22.80
Dividend yield 1.2%
Turnover / mcap —
Returns  
ROE 11.4%
ROI 10.2%
ROIC 10.9%
Profit margin 14.0%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 0.05%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 42
Quality score 27.8%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 351.363B 284.9B 238.883B 230.818B 208.159B 169.198B 130.973B 113.059B 94.471B 78.143B 64.66B 51.376B 36.887B 26.008B
Net profit 49.1B 40.484B 45.271B 49.028B 63.845B 37.822B 21.635B 19.577B 19.684B 16.004B 12.508B 8.861B 8.318B 5.599B
Free cash flow 58.332B 42.752B 50.729B 49.536B 48.891B 44.638B 23.949B 16.404B — — — — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 1.604K 1.7K 2.138K 3.301K 4.468K 7.572K 3.195K 1.856K 4.779K 2.764K 1.416K 1.275K 1.694K 909.2
Price performance 12m -0.06 -0.2 -0.35 -0.26 -0.41 1.37 0.72 -0.61 0.73 0.95 0.11 -0.25 0.86 —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) — 24.9B 28.3B 33.6B 43.7B 50.9B 50.5B 51.9B 65B 74.6B
↳ YoY growth +13.7% +18.7% +29.9% +16.5% -0.7% +2.8% +25.3% +14.7%
↳ 5y CAGR +15.2% +12.9% +14.1% +11.3%
Borrowings, current (JPY) — — — — — — 17M 2.03B 3.08B 4.17B
Borrowings, non-current (JPY) — — — — — — 94M 16.5B 21.3B 29B
Cash and deposits (JPY) 20.1B 23.7B 27.5B 47.9B 89.1B 104B 118B 150B 135B 156B
Intangible assets (JPY) — 12.8B 12.7B 20.2B 23B 25.1B 40.7B 51.6B 94.9B 99.2B
Right-of-use assets (JPY) — — — — — 7.52B 9.47B 12.1B 25.9B 25.3B
Net debt (borrowings + leases - cash) (JPY) — — — — — — -118B -131B -111B -123B
Cash flow detail
Operating cash flow (JPY) 16.6B 15.9B 17.7B 26.8B 46.6B 52.1B 57.1B 58.3B 51.7B 70.3B
Purchases of property, plant and equipment (JPY) — -1.39B -677M -1.85B -1.23B -1.71B -5.91B -5.41B -6.29B -7.68B
Purchases of intangible assets (JPY) — -463M -668M -992M -759M -1.51B -1.67B -2.17B -2.7B -4.25B
Change in receivables (cash effect) (JPY) — -3.99B -2.74B -4.22B -9.49B -8.84B 3.09B 2.25B -2.52B -2.27B
Change in payables (cash effect) (JPY) — 447M 304M 1.11B 2.24B 6.57B 129M 2.44B -962M 2.31B
Dividends paid (cash effect) (JPY) — -3.24B -3.35B -4.53B -5.77B -8.14B -10.9B -12.9B -14.3B -14.3B
Share buybacks (cash effect) (JPY) — — -1M — — — — — 0.00 -20B
Interest paid (cash effect) (JPY) — -7M -35M -38M -48M -52M -68M -387M -717M -997M
Operating cash flow before change in receivables (JPY) — 19.9B 20.5B 31B 56.1B 60.9B 54B 56.1B 54.3B 72.5B
Free cash flow (OCF - PPE - intangibles) (JPY) — 14.1B 16.4B 23.9B 44.6B 48.9B 49.5B 50.7B 42.8B 58.3B
Income detail
Research and development expense (JPY) — — 21M 9M 46M — — — — —
Total comprehensive income (JPY) — 19.6B 21.4B 22.3B 43.8B 70.8B 62.9B 64.1B 41.7B 68.2B
Comprehensive income to owners (JPY) 15B 18.5B 19.7B 19.9B 40.1B 68.4B 59.9B 60.5B 38.3B 62.7B
Segments
Career Solution · Segment revenue (JPY) — 10.9B 13.7B 15.4B 13.5B 14.1B 14.5B 16.6B 20.9B 22.8B
↳ YoY growth +26.0% +12.3% -12.1% +4.1% +3.2% +14.5% +25.7% +9.0%
Career Solution · Segment operating income (JPY) — 2.87B 3.85B 4.15B 3.75B 4.65B 4.64B 4.78B 5.66B 5.93B
Evidence Solution · Segment revenue (JPY) — 22.1B 22.6B 21.4B 19.5B 22.8B 27.2B 26.7B 24.2B 24.5B
↳ YoY growth +2.5% -5.6% -8.9% +16.9% +19.3% -1.7% -9.2% +1.1%
Evidence Solution · Segment operating income (JPY) — 5.53B 5.99B 4.7B 3.62B 5.65B 7.66B 6.7B 4.35B 5.12B
Medical Platform · Segment revenue (JPY) — 34.3B 41.2B 51.3B 77.1B 85.9B 93.1B 93.4B 91.6B 108B
↳ YoY growth +20.2% +24.3% +50.3% +11.5% +8.3% +0.3% -2.0% +17.8%
Medical Platform · Segment operating income (JPY) — 15.4B 15.4B 19.3B 37.9B 39.6B 41.1B 38.6B 34.1B 35.9B
Overseas · Segment revenue (JPY) — 22.4B 25.1B 30B 42.1B 51.8B 62.1B 69.9B 80.6B 86.9B
↳ YoY growth +12.0% +19.3% +40.7% +23.0% +19.8% +12.5% +15.3% +7.9%
Overseas · Segment operating income (JPY) — 2.98B 3.64B 5.72B 12.6B 44.8B 17B 11.7B 14.7B 14.9B
Patient Solution · Segment revenue (JPY) — — — — — — — — 21.9B 56.9B
↳ YoY growth +159.5%
Patient Solution · Segment operating income (JPY) — — — — — — — — 824M 2.69B
Site Solution · Segment revenue (JPY) — — 9.18B 12.2B 16.6B 35.2B 35.3B 33B 47B 54.4B
↳ YoY growth +33.1% +35.4% +112.5% +0.3% -6.4% +42.4% +15.5%
Site Solution · Segment operating income (JPY) — — 881M 944M 1.54B 3.4B 3.75B 3.74B 5.42B 5.77B
Reported Jun 30, 2017 Jun 28, 2019 Jun 30, 2020 Jun 30, 2020 Jun 28, 2021 Jun 29, 2023 Jun 27, 2024 Jun 27, 2024 Jun 25, 2026 Jun 25, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

2027年3月期 第2四半期 決算説明資料 Bull 0 Bear 0 Results

Prompts

M3, Inc. (ticker 2413), listed in Japan.

ETFs Holding M3, Inc.

ETF Weight in ETF Shares Market value As of
JAPN 1.98% 41,000 $ 457.868K Jun 30, 2026
DFSI 0.08% 80,900 $ 933.209K Nov 12, 2026
AVSD 0.04% 11,900 $ 134.893K Nov 16, 2026
DFIC 0.04% 529,471 $ 6.108M Nov 12, 2026
JSTC 0.03% 6,650 $ 75.866K Nov 17, 2026
DFAX 0.02% 216,400 $ 2.496M Nov 12, 2026
DFAI 0.02% 319,500 $ 3.686M Nov 12, 2026
NTSI 0.02% 8,200 $ 91.574K Jun 30, 2026
DXIV 0.01% 3,000 $ 34.606K Nov 12, 2026
AVDE 0.01% 251,100 $ 2.846M Nov 16, 2026